These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 11279720

  • 1. Cabergoline for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KH.
    Cochrane Database Syst Rev; 2001; 2001(1):CD001518. PubMed ID: 11279720
    [Abstract] [Full Text] [Related]

  • 2. Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KD.
    Cochrane Database Syst Rev; 2001; 2001(1):CD001519. PubMed ID: 11279721
    [Abstract] [Full Text] [Related]

  • 3. Ropinirole for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KH.
    Cochrane Database Syst Rev; 2000; (3):CD001516. PubMed ID: 10908503
    [Abstract] [Full Text] [Related]

  • 4. Ropinirole for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KH.
    Cochrane Database Syst Rev; 2001; (1):CD001516. PubMed ID: 11279718
    [Abstract] [Full Text] [Related]

  • 5. Pramipexole for levodopa-induced complications in Parkinson's disease.
    Clarke C E, Speller J M, Clarke J A.
    Cochrane Database Syst Rev; 2000; 2000(3):CD002261. PubMed ID: 10908540
    [Abstract] [Full Text] [Related]

  • 6. Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke C E, Speller J M, Clarke J A.
    Cochrane Database Syst Rev; 2000; 2000(3):CD002259. PubMed ID: 10908539
    [Abstract] [Full Text] [Related]

  • 7. Ropinirole versus bromocriptine for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Deane KH.
    Cochrane Database Syst Rev; 2001; (1):CD001517. PubMed ID: 11279719
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Pergolide versus bromocriptine for levodopa-induced motor complications in Parkinson's disease.
    Clarke C E, Speller J M.
    Cochrane Database Syst Rev; 2000; (2):CD000236. PubMed ID: 10796705
    [Abstract] [Full Text] [Related]

  • 12. The long-acting dopamine receptor agonist cabergoline in early Parkinson's disease: final results of a 5-year, double-blind, levodopa-controlled study.
    Bracco F, Battaglia A, Chouza C, Dupont E, Gershanik O, Marti Masso JF, Montastruc JL, PKDS009 Study Group.
    CNS Drugs; 2004; 18(11):733-46. PubMed ID: 15330687
    [Abstract] [Full Text] [Related]

  • 13. Catechol-O-methyltransferase inhibitors for levodopa-induced complications in Parkinson's disease.
    Deane KH, Spieker S, Clarke CE.
    Cochrane Database Syst Rev; 2004 Oct 18; 2004(4):CD004554. PubMed ID: 15495119
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Lisuride for levodopa-induced complications in Parkinson's disease.
    Clarke CE, Speller JM.
    Cochrane Database Syst Rev; 2000 Oct 18; 1999(2):CD001515. PubMed ID: 10796801
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.
    Stowe R, Ives N, Clarke CE, Deane K, van Hilten, Wheatley K, Gray R, Handley K, Furmston A.
    Cochrane Database Syst Rev; 2010 Jul 07; (7):CD007166. PubMed ID: 20614454
    [Abstract] [Full Text] [Related]

  • 19. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis.
    Talati R, Baker WL, Patel AA, Reinhart K, Coleman CI.
    Int J Clin Pract; 2009 Apr 07; 63(4):613-23. PubMed ID: 19222614
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.